Cargando…

Interleukin-6 inhibitors in non-COVID-19 ARDS: analyzing the past to step into the post-COVID-19 era

Detalles Bibliográficos
Autores principales:	Gandini, Lucia, Fior, Gabriele, Schibler, Andreas, Obonyo, Nchafatso G., Li Bassi, Gianluigi, Suen, Jacky Y., Fraser, John F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039681/ https://www.ncbi.nlm.nih.gov/pubmed/36966340 http://dx.doi.org/10.1186/s13054-023-04394-w

Ejemplares similares

Intravenous immunoglobulin therapy for COVID-19 ARDS
por: Wilfong, Erin M, et al.
Publicado: (2022)

Epidemiology and outcomes of early-onset AKI in COVID-19-related ARDS in comparison with non-COVID-19-related ARDS: insights from two prospective global cohort studies
por: McNicholas, Bairbre A., et al.
Publicado: (2023)

Correction : Epidemiology and outcomes of early-onset AKI in COVID-19-related ARDS in comparison with non-COVID-19-related ARDS: insights from two prospective global cohort studies
por: McNicholas, Bairbre A., et al.
Publicado: (2023)

Cytokine adsorption during ECMO for COVID-19-related ARDS
por: Shekar, Kiran, et al.
Publicado: (2021)

The discovery of biological subphenotypes in ARDS: a novel approach to targeted medicine?
por: Wildi, Karin, et al.
Publicado: (2021)

Higher PEEP in intubated COVID-19-associated ARDS patients? We are not sure
por: Yaroshetskiy, Andrey I., et al.
Publicado: (2022)

Correction to: The discovery of biological subphenotypes in ARDS: a novel approach to targeted medicine?
por: Wildi, Karin, et al.
Publicado: (2021)

COVID-19: why not learn from the past?
por: Zocchi, Elena, et al.
Publicado: (2021)

ECMO use in COVID-19: lessons from past respiratory virus outbreaks—a narrative review
por: Cho, Hwa Jin, et al.
Publicado: (2020)

Diagnosis of EVALI in the COVID-19 era
por: Kazachkov, Mikhail, et al.
Publicado: (2020)

COVID-19-related ARDS: one disease, two trajectories, and several unanswered questions
por: Lascarrou, Jean-Baptiste
Publicado: (2021)

The conundrum of interleukin-6 blockade in COVID-19
por: Campochiaro, Corrado, et al.
Publicado: (2020)

Novel paediatric presentation of COVID-19 with ARDS and cytokine storm syndrome without respiratory symptoms
por: Pain, Clare E, et al.
Publicado: (2020)

Offline: Science and politics in the era of COVID-19
por: Horton, Richard
Publicado: (2020)

Participant stress in the COVID-19 era and beyond
por: Goldfarb, Elizabeth V.
Publicado: (2020)

Prioritisation of COVID-19 boosters in the omicron era
por: Irving, Stephanie A, et al.
Publicado: (2022)

ECMO for severe ARDS associated with COVID-19: now we know we can, but should we?
por: Shekar, Kiran, et al.
Publicado: (2020)

Further validation of the efficacy of mesenchymal stem cell infusions for reducing mortality in COVID-19 patients with ARDS
por: Shetty, Ashok K., et al.
Publicado: (2021)

Management of mother–newborn dyads in the COVID-19 era
por: Medvedev, Melissa M
Publicado: (2020)

Bringing research directly to families in the era of COVID-19
por: Balevic, Stephen J., et al.
Publicado: (2020)

Challenges and opportunities to end tuberculosis in the COVID-19 era
por: Wingfield, Tom, et al.
Publicado: (2021)

Extracorporeal membrane oxygenation (ECMO) and the acute respiratory distress syndrome (ARDS): a systematic review of pre-clinical models
por: Millar, Jonathan E., et al.
Publicado: (2019)

Impact of renin–angiotensin–aldosterone system inhibition on mortality in critically ill COVID-19 patients with pre-existing hypertension: a prospective cohort study
por: Sato, Kei, et al.
Publicado: (2022)

Social license for the use of big data in the COVID-19 era
por: Shaw, James A., et al.
Publicado: (2020)

Mental health of health-care workers in the COVID-19 era
por: Greenberg, Neil
Publicado: (2020)

Functional status in the COVID-19 era: ALERT, ALERT, ALERT!
por: Marques, A.
Publicado: (2021)

Early immunomodulators with CAR T-cell immunotherapy in the COVID-19 era
por: Abid, Muhammad Bilal
Publicado: (2022)

Disease surveillance for the COVID-19 era: time for bold changes
por: Morgan, Oliver W, et al.
Publicado: (2021)

How to deal with hypertension in the COVID-19 era—the impact “ON” and “OF” hypertension
por: Ishida, Mari
Publicado: (2021)

A role for interleukin-1 receptor antagonism in severe COVID-19?
por: Tattersall, Rachel S, et al.
Publicado: (2021)

Cancer diagnostic delay in the COVID-19 era: what happens next?
por: Hamilton, William
Publicado: (2020)

Kawasaki disease in the COVID-19 era: a distinct clinical phenotype?
por: Kam, Kai-Qian, et al.
Publicado: (2020)

Neurological manifestations of rhino-oculo-cerebral mucormycosis in the COVID-19 era
por: Singh, Gagandeep, et al.
Publicado: (2021)

Prone position during venovenous extracorporeal membrane oxygenation: survival analysis needed for a time-dependent intervention
por: Zaaqoq, Akram M., et al.
Publicado: (2022)

COVID-19: time to plan for prompt universal access to diagnostics and treatments
por: Bassi, Luca Li, et al.
Publicado: (2020)

Genomics in the era of COVID-19: ethical implications for clinical practice and public health
por: Geller, Gail, et al.
Publicado: (2020)

Anxiety and hypertension in the COVID-19 era: how is the central autonomic network linked?
por: Nagai, Michiaki, et al.
Publicado: (2022)

Restrictive abortion laws, COVID-19, telehealth, and medication abortion in the SDG era
por: Awowole, Ibraheem O, et al.
Publicado: (2022)

Assessment and diagnosis of right ventricular failure—retrospection and future directions
por: Ro, Sun Kyun, et al.
Publicado: (2023)

Exploration of the Utility of Speckle-Tracking Echocardiography During Mechanical Ventilation and Mechanical Circulatory Support
por: Sato, Kei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5lrn1f7po5onv4kqln7tr9itot